CPSF4 and breast carcinoma: By integrating multiple in vitro assays, including cell viability, migration, flow cytometry, western blotting, and fluorescence microscopy, this research provides a comprehensive mechanistic evaluation of NAR's therapeutic potential in breast cancer.